Related Experiment Video
Updated: Jul 2, 2026
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Choice and interpretation of statistical tests used when competing risks are present
James J Dignam1, Maria N Kocherginsky
1Department of Health Studies, The University of Chicago, Chicago, IL 60637, USA. jdignam@health.bsd.uchicago.edu
Summary
In cancer research, analyzing competing risks requires careful consideration of different statistical metrics. Understanding cause-specific hazards and cumulative incidence functions is crucial for accurate clinical trial interpretation.
Area of Science:
- Biostatistics
- Clinical Oncology
- Epidemiology
Background:
- Clinical cancer research frequently encounters competing risks, where multiple event types can occur simultaneously.
- Examples include tumor recurrence, secondary cancers, or non-cancer death in patients undergoing treatment.
- Standard statistical methods must account for these competing events to accurately interpret outcomes.
Purpose of the Study:
- To compare the utility of cause-specific hazard functions and cumulative incidence functions in analyzing competing risks in cancer clinical trials.
- To provide guidance on selecting appropriate metrics based on the research question.
- To illustrate the impact of metric choice on inferential results through simulations and real-world examples.
Main Methods:
- The study reviews two primary metrics for competing risks: cause-specific hazard (CSH) and cumulative incidence function (CIF).
- Statistical tests based on CSH (e.g., log-rank) and CIF are compared.
- Simulation studies and examples from cancer clinical trials are used for illustration and guidance.
Main Results:
- Inferential results can differ significantly depending on whether CSH or CIF is used for analysis.
- The choice of metric impacts the interpretation of treatment effects in the presence of competing risks.
- Both metrics may be appropriate depending on the specific clinical question being addressed.
Conclusions:
- Selecting the correct statistical metric is vital for accurate analysis of competing risks in cancer clinical trials.
- Understanding the nuances between CSH and CIF is essential for researchers and clinicians.
- This study offers practical guidance for navigating complex competing risks scenarios in oncology research.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:14Decision Making: Traditional Method
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
01:19The Mantel-Cox Log-Rank Test
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.
01:21Introduction to Test of Independence
In statistics, the term independence means that one can directly obtain the probability of any event involving both variables by multiplying their individual probabilities. Tests of independence are chi-square tests involving the use of a contingency table of observed (data) values.
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
01:14Errors In Hypothesis Tests
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.